The study tackled a persistent problem in microbiome science. Most gut microbiota studies of psychiatric and addictive disorders have been conducted in single, relatively homogeneous populations, which makes it difficult to know whether observed microbial changes are genuinely tied to the disease or merely reflect the dietary habits, environment, or genetic background of one particular group. Ethnicity is known to shape the gut microbiome substantially, so a microbial alteration seen in one population might simply be noise when viewed against a different genetic and cultural backdrop. To address this, the team designed a multi-center study recruiting patients from two hospitals in different regions of China, one serving a predominantly Han population and the other serving Uyghur participants, whose traditional dietary patterns and genetic ancestry differ considerably from those of Han Chinese.

Methodologically, the researchers went beyond the 16S ribosomal RNA surveys that dominate much of the microbiome literature. They used shotgun metagenomic sequencing, a technique in which all microbial DNA in a stool sample is fragmented and sequenced directly, allowing researchers to identify not only which bacterial species are present but also which functional genes and metabolic pathways they carry. This higher-resolution approach matters because two microbial communities can look similar at the genus level while differing dramatically in what they are actually doing. The team constructed an Integrated Gene Catalog from their sequencing data and compared taxonomic composition and functional pathways between patients with alcohol use disorder and matched healthy controls within each ethnic group, and then across both groups simultaneously.

To ensure that the observed differences were attributable to the disorder itself rather than confounding variables such as age, body mass index, or co-occurring health conditions, the investigators applied propensity score matching, a statistical technique borrowed from epidemiology that pairs patients and controls on measurable covariates. Differences in microbial community structure were tested with principal coordinates analysis and permutational multivariate analysis of variance, while differential abundance of individual species and pathways was assessed with statistical tools including the Linear Discriminant Analysis Effect Size method and the Statistical Analysis of Metagenomic Profiles, with false discovery rate correction applied to guard against spurious findings. The study was approved by the ethics committee of the Second Xiangya Hospital and conducted under the Declaration of Helsinki, with written informed consent from all participants.

The results confirmed that active alcohol use disorder is associated with significant disruption of the gut microbiota in both populations. When the researchers visualized the overall microbial communities, patients with the disorder clustered apart from healthy controls within each ethnic group, indicating that the disease leaves a detectable imprint on community structure. Yet the more striking finding emerged when the two patient groups were compared with each other. Despite distinct baseline ethnic profiles between Han and Uyghur healthy individuals, a robust shared signature appeared under active alcohol use disorder, characterized by the depletion of specific commensal taxa, particularly bacteria known to produce short-chain fatty acids.

Short-chain fatty acids, including acetate, propionate, and butyrate, are the metabolic currency of a healthy gut. These molecules are manufactured by certain commensal bacteria as they ferment dietary fiber, and they serve as the primary energy source for the cells lining the colon, help maintain the integrity of the intestinal barrier, modulate immune signaling, and communicate with the nervous system through the gut-brain axis. A consistent loss of short-chain fatty acid producers is therefore more than a taxonomic curiosity; it suggests a functional erosion of the gut’s capacity to regulate inflammation and barrier function, processes increasingly implicated in the systemic and neural consequences of heavy alcohol consumption.

At the species level, the convergence was remarkably specific. Four beneficial commensals were consistently and significantly depleted in both the Han and Uyghur patient groups, with statistical significance surviving false discovery rate correction. These were Fusicatenibacter saccharivorans, Eubacterium hallii, Ruminococcus torques, and Dorea formicigenerans. Each of these organisms is regarded as a health-associated member of the intestinal community. Eubacterium hallii, for example, is a well-studied producer of butyrate and propionate, while Fusicatenibacter saccharivorans has been linked to anti-inflammatory activity in prior research. The fact that the same four species dropped out in parallel across two ancestrally and culturally distinct cohorts suggests that chronic alcohol exposure exerts a selective pressure on the gut ecosystem that overrides baseline ethnic differences.

The functional analysis deepened the picture further. When the researchers examined microbial metabolic pathways rather than species identities, they found convergent functional disturbances shared by both patient groups. Core microbial DNA replication pathways were depleted, as were DNA repair mechanisms, specifically mismatch repair and homologous recombination, and the protein translation pathway of aminoacyl-tRNA biosynthesis. These are fundamental housekeeping functions of microbial life, and their consistent reduction points to a state of broad metabolic and replicative stress within the gut microbial community of patients with active alcohol use disorder. Alcohol and its metabolite acetaldehyde are known genotoxic agents, and the observed depletion of microbial DNA maintenance machinery may reflect direct damage to microbial genomes or a shift in community composition away from organisms that invest heavily in genome upkeep.

The authors are careful to frame these findings as hypothesis-generating rather than definitive. The study was cross-sectional, meaning it captured a snapshot of the gut microbiota at a single point in time, so it cannot determine whether the microbial depletions are a cause of alcohol use disorder, a consequence of chronic drinking, or a mixture of both. The cohorts were composed of male participants, which limits generalizability to women. Longitudinal studies that follow individuals over time, ideally through periods of drinking and abstinence, will be needed to establish the direction of the relationship and to test whether the depleted commensals recover with sobriety. The researchers explicitly position the consistent loss of short-chain fatty acid producers as candidate features for future longitudinal validation and mechanistic exploration.

Even so, the implications are considerable. If the shared microbial signature holds up in larger and more diverse cohorts, it could inform the development of microbiome-based biomarkers for alcohol use disorder, complementing clinical and psychological assessment. It also raises the possibility of therapeutic intervention. Fecal microbiota transplantation and targeted probiotic or dietary strategies aimed at restoring short-chain fatty acid producers are already being explored for other conditions, and the gut-liver axis, the bidirectional communication between intestinal microbes and hepatic physiology, is a central pathway in alcoholic liver disease. Restoring a depleted commensal community might not treat addiction itself, but it could mitigate some of the intestinal and systemic damage that accompanies heavy drinking. By demonstrating that the same microbial casualties appear in two very different populations, this study moves the field a step closer to distinguishing the genuine biological footprint of alcohol use disorder from the background noise of human diversity, and it underscores a simple message that is resonating across modern medicine: to understand disorders of the brain, researchers increasingly need to look at the gut.

Subject of Research: Shared gut microbiota alterations in Han and Uyghur patients with alcohol use disorder

Article Title: Shared microbial alterations in Han and Uyghur patients with alcohol use disorder

Article References: Ding, Q., Hu, H., Xu, X., Chen, T., & Zhang, X. (2026). Shared microbial alterations in Han and Uyghur patients with alcohol use disorder. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08752-0

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08752-0

Keywords: alcohol use disorder, gut microbiota, shotgun metagenomics, short-chain fatty acids, dysbiosis, gut-brain axis, gut-liver axis, ethnicity, microbiome, psychiatry, commensal bacteria, DNA repair pathways